Leydig cell tumor of the ovary in a postmenopausal woman presenting with virilization

Irina Bancos, Herbert D. Prawius

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Mild hyperandrogenism associated with anovulation or hirsutism is present in 5% of women. Severe hyperandrogenism associated with virilization is much less common. It may be caused by either benign or malignant neoplasms of adrenal or ovarian origin. We report a case of a virilizing steroid cell ovarian tumor in a 78-year-old postmenopausal woman. Although the biochemical evaluation pointed to an ovarian source of androgen, diagnostic attempts to localize the source of hyperandrogenism with transvaginal ultrasound and computed tomography scan of pelvis and abdomen failed. Venous sampling was considered, but the patient opted for bilateral salpingo-oophorectomy. Section of the right ovary revealed a well-demarcated tumor measuring 1.9 cm in greatest dimension. The tumor was composed of solid aggregates of polygonal cells with granular eosinophilic cytoplasm. Cytoplasmic lipofuscin was identified. Intracytoplasmic Reinke crystals were found. Within hours of surgery, biochemical markers of hyperandrogenism had resolved. This article reviews the clinical and biochemical presentation of tumorous ovarian virilization, histologic classification of ovarian virilizing tumors, currently used localization studies, including ovarian venous sampling, and concludes with a summary of therapeutic options for Leydig cell ovarian tumors.

Original languageEnglish (US)
Pages (from-to)146-149
Number of pages4
JournalEndocrinologist
Volume18
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Leydig Cell Tumor
Virilism
Hyperandrogenism
Ovary
Neoplasms
Adrenal Gland Neoplasms
Anovulation
Lipofuscin
Hirsutism
Ovariectomy
Pelvis
Abdomen
Ovarian Neoplasms
Androgens
Cytoplasm
Biomarkers
Steroids
Tomography

Keywords

  • Leydig cell tumor
  • Ovarian venous sampling
  • Reinke crystals
  • Steroid cell tumor
  • Virilization

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Leydig cell tumor of the ovary in a postmenopausal woman presenting with virilization. / Bancos, Irina; Prawius, Herbert D.

In: Endocrinologist, Vol. 18, No. 3, 05.2008, p. 146-149.

Research output: Contribution to journalReview article

Bancos, Irina ; Prawius, Herbert D. / Leydig cell tumor of the ovary in a postmenopausal woman presenting with virilization. In: Endocrinologist. 2008 ; Vol. 18, No. 3. pp. 146-149.
@article{377a5fbc16994cff85c0761091a096c9,
title = "Leydig cell tumor of the ovary in a postmenopausal woman presenting with virilization",
abstract = "Mild hyperandrogenism associated with anovulation or hirsutism is present in 5{\%} of women. Severe hyperandrogenism associated with virilization is much less common. It may be caused by either benign or malignant neoplasms of adrenal or ovarian origin. We report a case of a virilizing steroid cell ovarian tumor in a 78-year-old postmenopausal woman. Although the biochemical evaluation pointed to an ovarian source of androgen, diagnostic attempts to localize the source of hyperandrogenism with transvaginal ultrasound and computed tomography scan of pelvis and abdomen failed. Venous sampling was considered, but the patient opted for bilateral salpingo-oophorectomy. Section of the right ovary revealed a well-demarcated tumor measuring 1.9 cm in greatest dimension. The tumor was composed of solid aggregates of polygonal cells with granular eosinophilic cytoplasm. Cytoplasmic lipofuscin was identified. Intracytoplasmic Reinke crystals were found. Within hours of surgery, biochemical markers of hyperandrogenism had resolved. This article reviews the clinical and biochemical presentation of tumorous ovarian virilization, histologic classification of ovarian virilizing tumors, currently used localization studies, including ovarian venous sampling, and concludes with a summary of therapeutic options for Leydig cell ovarian tumors.",
keywords = "Leydig cell tumor, Ovarian venous sampling, Reinke crystals, Steroid cell tumor, Virilization",
author = "Irina Bancos and Prawius, {Herbert D.}",
year = "2008",
month = "5",
doi = "10.1097/TEN.0b013e318171b80e",
language = "English (US)",
volume = "18",
pages = "146--149",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Leydig cell tumor of the ovary in a postmenopausal woman presenting with virilization

AU - Bancos, Irina

AU - Prawius, Herbert D.

PY - 2008/5

Y1 - 2008/5

N2 - Mild hyperandrogenism associated with anovulation or hirsutism is present in 5% of women. Severe hyperandrogenism associated with virilization is much less common. It may be caused by either benign or malignant neoplasms of adrenal or ovarian origin. We report a case of a virilizing steroid cell ovarian tumor in a 78-year-old postmenopausal woman. Although the biochemical evaluation pointed to an ovarian source of androgen, diagnostic attempts to localize the source of hyperandrogenism with transvaginal ultrasound and computed tomography scan of pelvis and abdomen failed. Venous sampling was considered, but the patient opted for bilateral salpingo-oophorectomy. Section of the right ovary revealed a well-demarcated tumor measuring 1.9 cm in greatest dimension. The tumor was composed of solid aggregates of polygonal cells with granular eosinophilic cytoplasm. Cytoplasmic lipofuscin was identified. Intracytoplasmic Reinke crystals were found. Within hours of surgery, biochemical markers of hyperandrogenism had resolved. This article reviews the clinical and biochemical presentation of tumorous ovarian virilization, histologic classification of ovarian virilizing tumors, currently used localization studies, including ovarian venous sampling, and concludes with a summary of therapeutic options for Leydig cell ovarian tumors.

AB - Mild hyperandrogenism associated with anovulation or hirsutism is present in 5% of women. Severe hyperandrogenism associated with virilization is much less common. It may be caused by either benign or malignant neoplasms of adrenal or ovarian origin. We report a case of a virilizing steroid cell ovarian tumor in a 78-year-old postmenopausal woman. Although the biochemical evaluation pointed to an ovarian source of androgen, diagnostic attempts to localize the source of hyperandrogenism with transvaginal ultrasound and computed tomography scan of pelvis and abdomen failed. Venous sampling was considered, but the patient opted for bilateral salpingo-oophorectomy. Section of the right ovary revealed a well-demarcated tumor measuring 1.9 cm in greatest dimension. The tumor was composed of solid aggregates of polygonal cells with granular eosinophilic cytoplasm. Cytoplasmic lipofuscin was identified. Intracytoplasmic Reinke crystals were found. Within hours of surgery, biochemical markers of hyperandrogenism had resolved. This article reviews the clinical and biochemical presentation of tumorous ovarian virilization, histologic classification of ovarian virilizing tumors, currently used localization studies, including ovarian venous sampling, and concludes with a summary of therapeutic options for Leydig cell ovarian tumors.

KW - Leydig cell tumor

KW - Ovarian venous sampling

KW - Reinke crystals

KW - Steroid cell tumor

KW - Virilization

UR - http://www.scopus.com/inward/record.url?scp=67650742826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650742826&partnerID=8YFLogxK

U2 - 10.1097/TEN.0b013e318171b80e

DO - 10.1097/TEN.0b013e318171b80e

M3 - Review article

AN - SCOPUS:67650742826

VL - 18

SP - 146

EP - 149

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 3

ER -